Candel Therapeutics (CADL)
(Delayed Data from NSDQ)
$10.83 USD
+1.24 (12.93%)
Updated May 8, 2024 04:00 PM ET
After-Market: $10.68 -0.15 (-1.39%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.38 |
Last EPS Surprise | -137.50% |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -0.91 |
Next Year | NA |
EPS (TTM) | -1.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.09M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -0.91 | NA |
# of Estimates | NA | NA | 1 | NA |
Most Recent Consensus | NA | NA | -0.91 | NA |
High Estimate | NA | NA | -0.91 | NA |
Low Estimate | NA | NA | -0.91 | NA |
Year ago EPS | -0.30 | -0.33 | -1.31 | -0.91 |
Year over Year Growth Est. | NA | NA | 30.53% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | NA |
Up Last 30 Days | NA | NA | 0 | NA |
Up Last 60 Days | NA | NA | 0 | NA |
Down Last 7 Days | NA | NA | 0 | NA |
Down Last 30 Days | NA | NA | 0 | NA |
Down Last 60 Days | NA | NA | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -0.91 | NA |
7 Days Ago | NA | NA | -0.91 | NA |
30 Days Ago | NA | NA | -0.91 | NA |
60 Days Ago | NA | NA | -0.91 | NA |
90 Days Ago | NA | NA | -0.91 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -0.91 | NA |
Zacks Consensus Estimate | NA | NA | -0.91 | NA |
Earnings ESP | NA | NA | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.29 | -0.33 | -0.30 | NA |
Estimate | -0.16 | -0.19 | -0.23 | NA | NA |
Difference | -0.22 | -0.10 | -0.10 | NA | -0.14 |
Surprise | -137.50% | -52.63% | -43.48% | NA | -77.87% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more